Cas:72822-13-0 Dapiprazole Hydrochloride manufacturer & supplier

We serve Chemical Name:Dapiprazole Hydrochloride CAS:72822-13-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Dapiprazole Hydrochloride

Chemical Name:Dapiprazole Hydrochloride
CAS.NO:72822-13-0
Synonyms:Rev-Eyes;Dapiprazole hydrochloride;AF 2139;1,2,4-Triazolo[4,3-a]pyridine, 5,6,7,8-tetrahydro-3-[2-[4-(2-methylphenyl)-1-piperazinyl]ethyl]-;5,6,7,8-Tetrahydro-3-[2-[4-(2-methylphenyl)-1-piperazinyl]ethyl]-1,2,4-triazolo[4,3-a]pyridine;Dapiprazole;Dapiprazole hydrochloride (USAN);Dapiprazole HCl;3-{2-[4-(2-Methylphenyl)piperazin-1-yl]ethyl}-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine;3-{2-[4-(2-Methylphenyl)-1-piperazinyl]ethyl}-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine;5,6,7,8-Tetrahydro-3-[2-(4-o-tolyl-1-piperazinyl)ethyl]-s-triazolo[4,3-a]pyridine
Molecular Formula:C19H28ClN5
Molecular Weight:361.91
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:538.9±60.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.658
PSA:37.19000
Exact Mass:
LogP:2.44

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Rev-Eyes chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5,6,7,8-Tetrahydro-3-[2-(4-o-tolyl-1-piperazinyl)ethyl]-s-triazolo[4,3-a]pyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,AF 2139 Use and application,Dapiprazole HCl technical grade,usp/ep/jp grade.


Related News: This not only makes it easier to remove enzyme residues from the desired product, but also ensures valuable high turnover enzymes can be reused multiple times without compromising their activity. 4-(1-((13,24,33,43,53,63-hexaoxin-2-yl)oxy)-1H-13,23,34,44,53,63,73,83,94-pentaoxolo[2,1]hexaoxin-3-yl)-3-hydroxy-11,24,33-tetraoxidan-2-one manufacturers CHMP also recommended for approval Sanofi and Genzyme’s new Pompe disease drug, known in Europe as Nexviadyme (avalglucosidase alfa). Pompe disease is a rare, inherited disorder caused by the buildup of glycogen in the body’s cells. Spiro[4.5]dec-1-ene-6,10-dione, 4-methoxy-8,8-dimethyl- suppliers Just weeks ago, Orchard touted research in The New England Journal of Medicine supporting the use of the therapy. The study included 30 patients treated with OTL-101 and found that all of them were still alive after two years. 2-((2-((4-(2-(tert-butyl)-6-propylpyrimidin-4-yl)-1,4-diazepan-1-yl)methyl)allyl)thio)pyrimidin-4(1H)-one oxalate vendor & factory.